Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for pain after radical cystectomy
NCT02355886Phase 3Completed
- Sponsor
- University of Washington
- Start
- Apr 2015
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gabapentin in postoperative pain, sponsored by University of Washington. Primary endpoint: Patient Total Equivalent Analgesic Requirement (Morphine Equivalents) at 48 hours. Started Apr 2015; status: completed.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02355886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02355886.